InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
3
T+90 hit rate
0%
T+90 mean return
-26.7%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by OConnell Daniel Joseph, Chairman & CEO. Officer active across 1 company, notably Acumen Pharmaceuticals, Inc.. Cumulatively, 10 disclosures have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €153k. Activity tracked since 30 November 2021. The latest transaction was filed on 21 January 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
12,619 shares@ US$1.59311.9% of flowCommon StockSEC:0001576885-25-000035:0
47,778 shares@ US$1.839252.8% of flowCommon StockSEC:0001576885-25-000021:0
225,400 shares0Common StockSEC:0001576885-25-000021:1
15,200 shares@ US$3.470629.9% of flowCommon StockSEC:0001576885-24-000029:0
401,000 shares0Common StockSEC:0001576885-24-000009:0
114,000 shares0Common StockSEC:0001209191-23-003741:0
1,118 shares@ US$4.472.7% of flowCommon StockSEC:0001209191-21-067613
1,118 shares@ US$4.470.0027% mcap50.0% of flowCommon StockSEC:0001209191-21-067613:0
123 sharesCommon StockSEC:0001209191-21-046029:0
123 sharesCommon StockSEC:0001209191-21-046029
10 of 10 declarations
About OConnell Daniel Joseph
Daniel Joseph O'Connell serves as the President and CEO of Acumen Pharmaceuticals, Inc. He is responsible for the strategic direction and operations of the company. O'Connell plays a key role in developing new initiatives and optimizing the services offered by Acumen.
